Pellegrino Gerardo, Zaccheroni Zoran, Tayeb Subhi, Oliverio Andrea, Mancuso Edoardo, Bonifazi Lorenzo, Giudice Amerigo, Barausse Carlo, Felice Pietro
Unit of Oral Surgery, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Clin Oral Implants Res. 2025 Aug 7. doi: 10.1111/clr.70017.
This study aimed to evaluate the survival rates of Mini Dental Implants (MDIs) placed in both the maxilla and the mandible, and their associated overdenture prostheses in edentulous patients over short-, medium-, and long-term follow-up periods.
Patients rehabilitated with Mini Dental Implants (diameter ≤ 2.9 mm) as support for overdenture prostheses with a minimum follow-up period of 3 years were included in the study. Data from eligible patients were collected, and marginal bone loss (MBL) was assessed for each implant. The primary outcomes for the prostheses and implants included failure rates, complications, and implant-related MBL.
The study analyzed 83 patients and 334 implants over an 8.09 ± 3.96-year mean follow-up. The cumulative implant survival rate at 15 years was 86.3% (95% CI: 79.5%-91.0%). Mean MBL increased from 0.09 ± 0.44 mm at implant placement to 1.79 ± 0.82 mm at 15 years, with Lodi Biomax implants exhibiting significantly lower annual bone loss compared to Dentatus Atlas implants (p < 0.001). The prosthetic survival rate was 95.45% (95% CI: 91.1-99.81). Longer follow-up (p = 0.018) and fewer adjustments (p < 0.001) reduced risks of complication occurrence. Additionally, Lodi Biomax implants had fewer complications compared to Dentatus Atlas (p = 0.039).
Mini Dental Implants with a diameter between 2.4 and 3 mm showed high survival rates over follow-ups of up to 15 years. Their use offers a viable prosthetic solution for edentulous patients, minimizing surgical invasiveness, rehabilitation time, and costs, particularly when a fixed prosthesis is either not feasible or not requested by the patient.
本研究旨在评估在无牙患者的上颌和下颌植入迷你牙种植体(MDIs)及其相关覆盖义齿在短期、中期和长期随访期的存活率。
本研究纳入了接受直径≤2.9mm的迷你牙种植体作为覆盖义齿支撑且随访期至少3年的患者。收集符合条件患者的数据,并评估每个种植体的边缘骨丢失(MBL)。义齿和种植体的主要结局包括失败率、并发症以及与种植体相关的MBL。
本研究在平均8.09±3.96年的随访期内分析了83例患者和334颗种植体。15年时种植体的累积存活率为86.3%(95%CI:79.5%-91.0%)。平均MBL从种植时的0.09±0.44mm增加到15年时的1.79±0.82mm,与Dentatus Atlas种植体相比,Lodi Biomax种植体的年骨丢失显著更低(p<0.001)。义齿存活率为95.45%(95%CI:91.1-99.81)。更长的随访时间(p=0.018)和更少的调整次数(p<0.001)降低了并发症发生的风险。此外,与Dentatus Atlas种植体相比,Lodi Biomax种植体的并发症更少(p=0.039)。
直径在2.4至3mm之间的迷你牙种植体在长达15年的随访期内显示出高存活率。它们的使用为无牙患者提供了一种可行的修复解决方案,可将手术侵入性、康复时间和成本降至最低,特别是在固定义齿不可行或患者不要求的情况下。